The partnership features a variety of initiatives including sponsorship of three races at the County Kildare venue. This race series features competitive handicaps on the opening day of the Curragh’s busy 2017 season on Saturday 13 May; day two of the Darley Irish Oaks Weekend, on Sunday 16 July, with the race series culminating with the Group 3 Plusvital Round Tower Stakes on Sunday 27 August.
As part of this new race series, Plusvital will be offering all horses competing within each of their sponsored races free genetic tests, in addition to a selection of supplement products for the winning connections.
As leaders in equine nutrition since 1975, Plusvital’s supplements and care products have been used by successful trainers and riders across the world.
Following its acquisition in 2015 of Equinome, the University College Dublin (UCD) equine genetic testing spin-out company, the company has continued to focus on the development of equine genetic tests, innovative nutraceuticals and other integrated equine performance and health products, which aim to maximise the potential success of individual racehorses.
Commenting on the launch of the race series, Mike Shelly, Plusvital, CEO, said, “Plusvital is delighted to be sponsoring three races this year at the Curragh, the home of Irish flat-racing. We are a proudly Irish company and this sponsorship reflects that.”
He added, “We have very exciting plans for Plusvital over the coming years and are confident that our multi-million euro investment in R&D will continue to provide new exciting scientifically-based products for trainers and owners on top of our existing range of supplements and genetic tests.”
Evan Arkwright, Commercial Manager, Curragh Racecourse, said, “It is exciting for the Curragh to renew our partnership with such a progressive company as Plusvital and we will work closely with Mike Shelly and his team to generate awareness of their products which will ultimately help them to win new customers.”
Plusvital is headquartered in Dún Laoghaire and maintains strong links with UCD though the company’s on-going, multi-million euro genomic and nutrition research programmme.